Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

South Korea to vaccinate pregnant women as it races to 80% target for adults

Published 10/05/2021, 11:59 PM
Updated 10/06/2021, 06:28 AM
© Reuters. South Korean senior citizens receive their first dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination centre in Seoul, South Korea April 1, 2021. Chung Sung-Jun/Pool via REUTERS

By Hyonhee Shin

SEOUL (Reuters) - South Korea will begin taking reservations for coronavirus vaccines from pregnant women this week as the country accelerates its inoculation drive to reach its goal for immunizing 80% of all adults by the end of the month.

Health authorities see pregnant mothers as key to the campaign and sought to drum up participation through public notices and news conferences saying they have a greater possibility of serious illness and death if infected with COVID-19.

Pregnant women are eligible to sign up for a shot starting Friday, for inoculation set to begin on Oct. 18 using Pfizer (NYSE:PFE) or Moderna (NASDAQ:MRNA) vaccines, according to the Korea Disease Control and Prevention Agency (KDCA).

"The vaccines are safe for pregnant women and can meaningfully decrease their risks of contracting COVID-19 and becoming critically ill," KDCA director Jeong Eun-kyeong told a public briefing on Monday.

Of the 731 pregnant women infected with the virus in South Korea as of August, about 2% of them developed serious illnesses, more than six times that of women aged 20-45, according to the KDCA.

But officials have advised people with shorter than 12 weeks pregnancy to consult medical staff before getting a shot.

Some 54.5 of the country's 52 million population and around 63% of adults were fully vaccinated as of Tuesday, and authorities aim to complete vaccination for 80% of all adults by the end of October.

The government plans to begin vaccinating children aged 12-17 next month, and providing booster shots for people aged 75 or older and other priority groups next week, including those who live or work at nursing homes and care facilities.

Authorities are also mapping out a plan on how to live more normally with COVID-19 https://www.reuters.com/world/asia-pacific/skorea-planning-live-more-normally-with-covid-19-after-october-2021-09-08, to be implemented in phases starting later this month to gradually ease distancing rules and restrictions, though masks will still be mandatory at least in the initial stages.

The KDCA reported 2,028 cases for Tuesday, as the numbers resurged after the Korean thanksgiving Chuseok holidays.

© Reuters. South Korean senior citizens receive their first dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination centre in Seoul, South Korea April 1, 2021. Chung Sung-Jun/Pool via REUTERS

But the ongoing wave has seen far fewer serious infections than earlier outbreaks, with many older and more vulnerable people having received vaccines.

Critical cases hovered around 350, and total infections rose to 323,379, with 2,536 deaths.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.